BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 27581216)

  • 21. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
    Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.
    Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Wang G; Guo QH
    Curr Alzheimer Res; 2017; 14(10):1102-1108. PubMed ID: 28462717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalamic nuclei in frontotemporal dementia: Mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72.
    Bocchetta M; Iglesias JE; Neason M; Cash DM; Warren JD; Rohrer JD
    Hum Brain Mapp; 2020 Mar; 41(4):1006-1016. PubMed ID: 31696638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
    Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
    BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.
    Kim EJ; Kwon JC; Park KH; Park KW; Lee JH; Choi SH; Jeong JH; Kim BC; Yoon SJ; Yoon YC; Kim S; Park KC; Choi BO; Na DL; Ki CS; Kim SH
    Neurobiol Aging; 2014 May; 35(5):1213.e13-7. PubMed ID: 24387985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of regional cerebellar atrophy in genetic frontotemporal dementia.
    Bocchetta M; Cardoso MJ; Cash DM; Ourselin S; Warren JD; Rohrer JD
    Neuroimage Clin; 2016; 11():287-290. PubMed ID: 26977398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
    Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
    Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
    Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Greaves C; Russell LL; Clarke MTM; Peakman G; van Swieten J; Jiskoot L; Moreno F; Barandiaran M; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Karnath HO; Vandenberghe R; de Mendonça A; Maruta C; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
    Appl Neuropsychol Adult; 2022; 29(1):112-119. PubMed ID: 32024404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.
    Sellami L; Bocchetta M; Masellis M; Cash DM; Dick KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Finger E; de Mendonça A; Sorbi S; Warren JD; Rohrer JD; Laforce R;
    J Alzheimers Dis; 2018; 65(1):147-163. PubMed ID: 30010122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Progressive Aphasia Associated With
    Saracino D; Ferrieux S; Noguès-Lassiaille M; Houot M; Funkiewiez A; Sellami L; Deramecourt V; Pasquier F; Couratier P; Pariente J; Géraudie A; Epelbaum S; Wallon D; Hannequin D; Martinaud O; Clot F; Camuzat A; Bottani S; Rinaldi D; Auriacombe S; Sarazin M; Didic M; Boutoleau-Bretonnière C; Thauvin-Robinet C; Lagarde J; Roué-Jagot C; Sellal F; Gabelle A; Etcharry-Bouyx F; Morin A; Coppola C; Levy R; Dubois B; Brice A; Colliot O; Gorno-Tempini ML; Teichmann M; Migliaccio R; Le Ber I;
    Neurology; 2021 Jul; 97(1):e88-e102. PubMed ID: 33980708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter hyperintensities are seen only in
    Sudre CH; Bocchetta M; Cash D; Thomas DL; Woollacott I; Dick KM; van Swieten J; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Laforce R; Finger E; de Mendonça A; Sorbi S; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2017; 15():171-180. PubMed ID: 28529873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia.
    Poos JM; Grandpierre LDM; van der Ende EL; Panman JL; Papma JM; Seelaar H; van den Berg E; van 't Klooster R; Bron E; Steketee R; Vernooij MW; Pijnenburg YAL; Rombouts SARB; van Swieten J; Jiskoot LC
    Neurology; 2022 Dec; 99(24):e2661-e2671. PubMed ID: 36288997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
    Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155
    [No Abstract]   [Full Text] [Related]  

  • 37. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
    Wilke C; Reich S; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Frisoni G; Ghidoni R; Sorbi S; Bocchetta M; Todd E; Kuhle J; Barro C; ; Rohrer JD; Synofzik M
    Ann Neurol; 2022 Jan; 91(1):33-47. PubMed ID: 34743360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Language impairment in the genetic forms of behavioural variant frontotemporal dementia.
    Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; van Swieten JC; Seelaar H; Jiskoot L; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
    J Neurol; 2023 Apr; 270(4):1976-1988. PubMed ID: 36538154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
    Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
    Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort.
    Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; van Swieten JC; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
    J Neurol Sci; 2023 Aug; 451():120711. PubMed ID: 37348248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.